In addition, while excluding confounding factors that could affect myocardial damage and LV function, our protocol includes serial multiple measurements of high-sensitivity CRP, multi-year follow-up, monitoring MACE, and HFH as a primary endpoint representing the validated symptomatic HF. Here, CRP is linked to hydrops fetalis.